Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Leaders of the Senate and House Judiciary Committees, led by Sen. Patrick Leahy (D-VT), re-introduced legislation to combat anticompetitive practices that can block the market entry of lower-cost generic drugs.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply